References
- Astor MC, Løvås K, Debowska A, et al. Epidemiology and health-related quality of life in hypoparathyroidism in Norway. J Clin Endocrinol Metab. 2016; 101(8):3045–3053.
- Brandi ML, Bilezikian JP, Shoback D, et al. Management of hypoparathyroidism: summary statement and guidelines. J Clin Endocrinol Metab. 2016; 101(6):2273–2283.
- Bilezikian JP, Khan A, Potts JT, et al. Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res. 2011; 26(10):2317–2337.
- Lorente-Poch L, Sancho JJ, Ruiz S, et al. . Importance of in situ preservation of parathyroid glands during total thyroidectomy. Br J Surg. 2015; 102(4):359–367.
- Page C, Strunski V. Parathyroid risk in total thyroidectomy for bilateral, benign, multinodular goitre: report of 351 surgical cases. J Laryngol Otol. 2007; 121(3):237–241.
- Asari R, Passler C, Kaczirek K, et al. Hypoparathyroidism after total thyroidectomy: a prospective study. Arch Surg. 2008; 143(2):132–137; discussion 138.
- White ML, Gauger PG, Doherty GM. Central lymph node dissection in differentiated thyroid cancer. World J Surg. 2007; 31(5):895–904.
- Ahmed N, Aurangzeb M, Muslim M, et al. Routine parathyroid autotransplantation during total thyroidectomy: a procedure with predictable outcome. J Pak Med Assoc. 2013; 63(2):190–193.
- El-Sharaky MI, Kahalil MR, Sharaky O, et al. Assessment of parathyroid autotransplantation for preservation of parathyroid function after total thyroidectomy. Head Neck. 2003; 25(10):799–807.
- Sitges-Serra A, Lorente-Poch L, Sancho J. Parathyroid autotransplantation in thyroid surgery. Langenbecks Arch Surg. 2018; 403(3):309–315.
- Su A, Gong Y, Wu W, et al. Effect of autotransplantation of a parathyroid gland on hypoparathyroidism after total thyroidectomy. Endocr Connect. 2018; 7(2):286–294.
- Wang B, Zhu C-R, Liu H, et al. The effectiveness of parathyroid gland autotransplantation in preserving parathyroid function during thyroid surgery for thyroid neoplasms: a Meta-analysis. PLoS One. 2019; 14(8):e0221173.
- Barczyński M, Gołkowski F, Nawrot I. Parathyroid transplantation in thyroid surgery. Gland Surg. 2017; 6(5):530–536.
- Akkan T, Dagdeviren M, Koca AO, et al. Alternate-day calcium dosing may be an effective treatment option for chronic hypoparathyroidism. J Endocrinol Invest. 2020; 43(6):853–858.
- Zavatta G, Clarke BL. Challenges in the management of chronic hypoparathyroidism. Endocr Connect. 2020;:9(10R229–40.
- Lou G, Chen Z, Zheng M, et al. Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases. Exp Mol Med. 2017; 49(6):e346.
- Vizoso FJ, Eiro N, Cid S, et al. Mesenchymal stem cell secretome: toward Cell-Free therapeutic strategies in regenerative medicine. Int J Mol Sci. 2017; 18(9):1852
- Marcucci G, Masi L, Cianferotti L, et al. Chronic hypoparathyroidism and treatment with teriparatide. Endocrine. 2021; 72(1):249–259.
- Yingjun X, Yuhuan X, Yuchang C, et al. CRISPR/Cas9 gene correction of HbH-CS thalassemia-induced pluripotent stem cells. Ann Hematol. 2019; 98(12):2661–2671.
- Luther DC, Lee YW, Nagaraj H, et al. Delivery approaches for CRISPR/Cas9 therapeutics in vivo: advances and challenges. Expert Opin Drug Deliv. 2018; 15(9):905–913.
- Edafe O, Balasubramanian SP. Incidence, prevalence and risk factors for post-surgical hypocalcaemia and hypoparathyroidism. Gland Surg. 2017; 6(Suppl 1):S59–s68.
- Fukushima H, Yoshioka M, Kawatou M, et al. Specific induction and long-term maintenance of high purity ventricular cardiomyocytes from human induced pluripotent stem cells. PLoS One. 2020; 15(11):e0241287.
- Hu W, Zi Z, Jin Y, et al. CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions. Cancer Immunol Immunother. 2019; 68(3):365–377.
- Jafari N, Kim H, Park R, et al. CRISPR-Cas9 mediated NOX4 knockout inhibits cell proliferation and invasion in HeLa cells. PLoS One. 2017; 12(1):e0170327.
- Meca-Cortés O, Guerra-Rebollo M, Garrido C, et al. CRISPR/Cas9-Mediated knockin application in cell therapy: a non-viral procedure for bystander treatment of glioma in mice. Mol Ther Nucleic Acids. 2017; 8:395–403.
- Lyu C, Shen J, Wang R, et al. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system. Stem Cell Res Ther. 2018; 9(1):92.
- Qu SW, Xue YN, Li P, et al. Advances in the research of stem cell tissue-engineering. Zhonghua Shao Shang Za Zhi. 2020;36(6):510–515.
- Hsu M-N, Chang Y-H, Truong VA, et al. CRISPR technologies for stem cell engineering and regenerative medicine. Biotechnol Adv. 2019; 37(8):107447.
- Gordon J, Bennett AR, Blackburn CC, et al. Gcm2 and Foxn1 mark early parathyroid- and thymus-specific domains in the developing third pharyngeal pouch. Mech Dev. 2001; 103(1-2):141–143.
- Günther T, Chen ZF, Kim J, et al. Genetic ablation of parathyroid glands reveals another source of parathyroid hormone. Nature. 2000; 406(6792):199–203.
- Yamada T, Tatsumi N, Anraku A, et al. Gcm2 regulates the maintenance of parathyroid cells in adult mice. PLoS One. 2019; 14(1):e0210662.
- Fan Y, Liu W, Bi R, et al. Interrelated role of Klotho and calcium-sensing receptor in parathyroid hormone synthesis and parathyroid hyperplasia. Proc Natl Acad Sci U S A. 2018; 115(16):E3749–e3758.
- Ritter CS, Finch JL, Slatopolsky EA, et al. Parathyroid hyperplasia in uremic rats precedes down-regulation of the calcium receptor. Kidney Int. 2001;60(5):1737–1744.